158 related articles for article (PubMed ID: 10494761)
1. Factor XIIa is a kinetically favorable plasminogen activator.
Schousboe I; Feddersen K; Røjkjaer R
Thromb Haemost; 1999 Sep; 82(3):1041-6. PubMed ID: 10494761
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro.
Tanaka A; Suzuki Y; Sugihara K; Kanayama N; Urano T
Life Sci; 2009 Jul; 85(5-6):220-5. PubMed ID: 19500599
[TBL] [Abstract][Full Text] [Related]
3. Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: a mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis.
Loza JP; Gurewich V; Johnstone M; Pannell R
Thromb Haemost; 1994 Mar; 71(3):347-52. PubMed ID: 8029800
[TBL] [Abstract][Full Text] [Related]
4. Contact activation prolongs clot lysis time in human plasma: role of thrombin-activatable fibrinolysis inhibitor and Factor XIII.
Nielsen VG; Steenwyk BL; Gurley WQ
J Heart Lung Transplant; 2006 Oct; 25(10):1247-52. PubMed ID: 17045938
[TBL] [Abstract][Full Text] [Related]
5. Factor XIIa activation of plasminogen is enhanced by contact activating surfaces and Zn2+.
Schousboe I
Blood Coagul Fibrinolysis; 1997 Mar; 8(2):97-104. PubMed ID: 9518051
[TBL] [Abstract][Full Text] [Related]
6. A spectrophotometric assay for the determination of the catalytic efficiency of plasminogen activators using a slowly hydrolyzed plasmin substrate.
Castro MJ; Kingston IB; Anderson S
Anal Biochem; 1995 Apr; 226(2):225-31. PubMed ID: 7793622
[TBL] [Abstract][Full Text] [Related]
7. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
Guimarães AH; Rijken DC
Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
[TBL] [Abstract][Full Text] [Related]
8. Corn trypsin inhibitor decreases tissue-type plasminogen activator-mediated fibrinolysis of human plasma.
Nielsen VG
Blood Coagul Fibrinolysis; 2009 Apr; 20(3):191-6. PubMed ID: 19657316
[TBL] [Abstract][Full Text] [Related]
9. In vitro studies on the fibrinolytic, thrombolytic and fibrinogenolytic properties of a tissue plasminogen activator from guinea pig keratocytes.
Electricwala A; Ling RJ; Sutton PM; Griffiths B; Riley PA; Atkinson T
Thromb Haemost; 1985 Apr; 53(2):200-3. PubMed ID: 4040659
[TBL] [Abstract][Full Text] [Related]
10. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
Vines DJ; Lee SW; Dichek DA; Ellis V
J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the in vitro fibrinolytic activities of low and high molecular weight single-chain urokinase-type plasminogen activator.
de Munk GA; Groeneveld E; Rijken DC
Thromb Haemost; 1993 Sep; 70(3):481-5. PubMed ID: 8259553
[TBL] [Abstract][Full Text] [Related]
12. Activated factor XII levels are dependent on factor XII 46C/T genotypes and factor XII zymogen levels, and are associated with vascular risk factors in patients and healthy subjects.
Ishii K; Oguchi S; Murata M; Mitsuyoshi Y; Takeshita E; Ito D; Tanahashi N; Fukuuchi Y; Oosumi K; Matsumoto K; Kitajima M; Yamamoto M; Watanabe G; Ikeda Y; Watanabe K
Blood Coagul Fibrinolysis; 2000 Apr; 11(3):277-84. PubMed ID: 10870808
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen activators and inhibitor type-1 in alveolar osteitis.
Serratì S; Margheri F; Bruschi S; D'Alessio S; Pucci M; Fibbi G; Tonelli P; Del Rosso M
Eur J Oral Sci; 2006 Dec; 114(6):500-3. PubMed ID: 17184232
[TBL] [Abstract][Full Text] [Related]
14. Role of the contact system in fibrinolysis.
Kluft C; Dooijewaard G; Emeis JJ
Semin Thromb Hemost; 1987 Jan; 13(1):50-68. PubMed ID: 3105061
[No Abstract] [Full Text] [Related]
15. Factor XII-induced fibrinolysis. Diminished proactivator activity and drastic reduction of activator activity in Fletcher factor-deficient plasma gamma globulin.
Espana F; Aznar J; Estelles A
J Lab Clin Med; 1982 Nov; 100(5):756-70. PubMed ID: 6182261
[TBL] [Abstract][Full Text] [Related]
16. Biological and thrombolytic properties of proenzyme and active forms of human urokinase--I. Fibrinolytic and fibrinogenolytic properties in human plasma in vitro of urokinases obtained from human urine or by recombinant DNA technology.
Zamarron C; Lijnen HR; Van Hoef B; Collen D
Thromb Haemost; 1984 Aug; 52(1):19-23. PubMed ID: 6495259
[TBL] [Abstract][Full Text] [Related]
17. The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin.
Ichinose A; Fujikawa K; Suyama T
J Biol Chem; 1986 Mar; 261(8):3486-9. PubMed ID: 3081506
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the abilities of plasma kallikrein, beta-Factor XIIa, Factor XIa and urokinase to activate plasminogen.
Miles LA; Greengard JS; Griffin JH
Thromb Res; 1983 Feb; 29(4):407-17. PubMed ID: 6344314
[TBL] [Abstract][Full Text] [Related]
19. Fibrinolytic properties of activated FXII.
Braat EA; Dooijewaard G; Rijken DC
Eur J Biochem; 1999 Aug; 263(3):904-11. PubMed ID: 10469157
[TBL] [Abstract][Full Text] [Related]
20. The intrinsic lysis concept.
Gurewich V; Liu JN; Pannell R
Ann N Y Acad Sci; 1992 Dec; 667():224-32. PubMed ID: 1309040
[No Abstract] [Full Text] [Related]
[Next] [New Search]
